OOIR: Observatory of International Research

Papers

(The H4-Index of Breast is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain	1592
A multicenter retrospective study of early cardiac toxicity in operable breast cancer patients receiving concurrent dual or mono anti-HER2 therapy with postoperative radiation therapy	155
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer	116
A multidisciplinary approach to optimizing care of patients treated with alpelisib	108
Patient-reported outcomes in bilateral prophylactic mastectomy with breast reconstruction: A narrative review	106
P035: Establishment of Newly Rapid and Accurate Intra-operative Examination of the Surgical Margin Status in Breast-Conserving Surgery by “Click-to-sense” Assay	92
Guide for Authors	74
P039: Pathological and clinical insights into postpartum and pregnancy-related breast cancer: Recurrence and tumor characteristics	64
P115: Preoperative Localization of Breast Lesions in the Case of Migration of the Stereotactic Biopsy Clip	61
P180: Baicalein sensitizes radio-resistant breast cancer cells by downregulating Rac1 signaling	59
P079: The impact of pre-operative Oncotype DX Breast Recurrence Scoretesting; the results of the PRE-DX randomised controlled trial	51
P116: HER2 Destiny: Visual scoring using ASCO/CAP guidelines or precise quantification using A.I?	49
P104: Primary and Secondary Breast Lymphoma: A Case Series	49
P067: Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer	46
P0102: Precision from pixels: A systematic review and Bayesian network meta-analysis comparing Tomosynthesis and AI-Augmented Mammography in Breast Cancer Detection	45
P031: Objective Response to Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study	45
P078: Impact of the SOUND trial on patient access to breast tumour profiling testing (Oncotype DX) and potential implications for adjuvant treatment decision	45
P170: Correlation between expression of p53-mutant, BCL-2 and response to anthracycline-based or taxane-based neoadjuvant chemotherapy in locally advanced breast cancer	42
P099: Utility and limitations of ultrasound-guided axillary lymph node fine-needle aspiration cytology in the pretreatment diagnosis of breast cancer	39
P287: The Clinical efficacy of the ICG Fluorescence injection technique with blue dye for sentinel lymph node biopsy using dual injection technique in early breast cancer patients	38
P149: Management of B3 breast lesions: clinical implications in light of the 2024 EUSOMA guidelines	37
P113: Li-Fraumeni: “Genetic testing of Breast/ovarian cancer patients unmask familial pathogenic germline variants in TP53 gene. Clinical implications and family counselling”	36
P239: A scoping review of treatments and services in longitudinal care trajectories after initial diagnosis and treatment of breast cancer	35
P328: Extent of resection in breast conserving surgery after neoadjuvant chemotherapy: a literature review	34
P367: Surgical management of ipsilateral breast cancer recurrence after conservative mastectomy and prepectoral implant reconstruction: exploring the role of wide local excision	33

P231: Outcomes of triple-negative breast cancer patients who developed thyroid dysfunction following Pembrolizumabcontaining regimens neoadjuvant chemotherapy	32
P202: PRIOR-HER2 - Pathologic Response Investigation of Oncologic Regions in HER2 Positive Breast Cancer: PHESGO in Indian setting	32
P207: Localization of the Sentinel Lymph Node with a Single Tracer after Neoadjuvant Chemotherapy in Patients with Initial cN+ Diagnosis	32
P213: Does response in primary breast cancer correlate with the axillary response after Neo-adjuvant chemotherapy in node-positive disease?	32
P182: Post-operative whole breast irradiation lowers mortality in earlystage, luminal A-like, low-risk, older breast cancer patients: an analysis from the EUSOMA database	32
P263: Hormone receptor levels and benefit from prolonged adjuvant tamoxifen therapy in postmenopausal breast cancer	31
P243: Partnership Between Breast Oncology Surgical Services and Hyperbaric Oxygen Therapy Unit Reduces Complications And Improves Outcomes	31
P264: Survival from ER-positive breast cancer in women who carry a BRCA1 mutation	31
P247: Challenges and Practices in Breast Cancer Surgery: A Nationwide Survey of Surgeons in Bangladesh	31